Updates on the mobilization pipeline for hematopoietic stem cell collection

Pharmacokinetics and Pharmacodynamics of Burixafor Hydrobromide (GPC‐100), a Novel C‐X‐C Chemokine Receptor 4 Antagonist and Mobilizer of Hematopoietic Stem/Progenitor Cells, in Mice and Healthy Subjects

(2023) Devki D. Sukhtankar et al.   Clinical Pharmacology in Drug Development

Therapeutic Perspectives of HIV-Associated Chemokine Receptor (CCR5 and CXCR4) Antagonists in Carcinomas

(2022) Wilfredo Alejandro González-Arriagada et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Machine learning-based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors

(2021) Jingyu Xiang et al.   Blood Advances

Mgta-145 + Plerixafor Provides GCSF-Free Rapid and Reliable Hematopoietic Stem Cell Mobilization for Autologous Stem Cell Transplant in Patients with Multiple Myeloma: A Phase 2 Study

(2021) Surbhi Sidana et al.   BLOOD

Cytokine‐induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche

(2019) Evert‐Jan F.M. Kruijf et al.   Annals of the New York Academy of Sciences

Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells

(2019) Darja Karpova et al.   JOURNAL OF CLINICAL INVESTIGATION

Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers

(2015) N Anandasabapathy et al.   BONE MARROW TRANSPLANTATION

Teriparatide (PTH 1-34) Treatment Increases Peripheral Hematopoietic Stem Cells in Postmenopausal Women

(2014) Elaine W Yu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations

(2013) Sergio Giralt et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma

(2013) A. Peled et al.   CLINICAL CANCER RESEARCH

The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)

(2009) Erik De Clercq   BIOCHEMICAL PHARMACOLOGY

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

(2009) J. F. DiPersio et al.   BLOOD

Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

(2009) John F. DiPersio et al.   JOURNAL OF CLINICAL ONCOLOGY